U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06954077) titled 'A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors' on April 24.
Brief Summary: This study is an open, multicenter, dose-escalation and expanded-enrollment, nonrandomized phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of BL-M09D1 for injection in patients with locally advanced or metastatic gastrointestinal tumors and other solid tumors.
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
Gastrointestinal Tumor
Solid Tumor
Intervention:
DRUG: BL-M09D1
Administration by intravenous ...